Cathay Capital
Wenwen Wenwen is an experienced investor and advisor in the Life Sciences and Health Ventures sectors, currently holding roles at Cathay Capital, as an Investor, and as an Angel Investor at a Startup, both since 2025. Additional advisory contributions are made to Stealth Biotech. Prior experience includes serving as a Senior Management Consultant at McKinsey & Company, where key advisory services spanned M&A, corporate strategy, and investment support for clients in Biotech, Pharma, and HealthTech. Notable roles also include business development in cell therapy at Cytovia Therapeutics, commercial leadership and product management at Celgene, as well as various strategic positions at Eli Lilly and Company and Novartis Oncology. Wenwen Wenwen holds an MBA from INSEAD and a B.Sc. in Pharmacology from Université de Sherbrooke.
This person is not in any teams
This person is not in any offices